Month,Gross margin
Celgene,93.1%
Novo Nordisk,88.1%
Amgen,82.8%
Biogen,81.8%
Gilead,78.2%
AbbVie,76.9%
Eli Lilly,73.8%
AstraZenca,71.8%
Bristol-Myers Squibb,71.3%
Roche,70.7%
Pfizer,70.2%
Merck & Co.,69.2%
GlaxoSmithKline,67.9%
Johnson & Johnson,66.7%
Novartis,64.5%
Sanofi,60.2%
Endo,45.8%
Allergan,44.2%
Teva,44%
Mylan,38%
